Pharma
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.
The partnership highlights the broader trend of AI-driven innovation in drug discovery and precision medicine.
The editors of Healthcare IT News, Healthcare Finance News and MobiHealthNews discuss the telehealth bill that was scuttled in 2024, as well as what's ahead in 2025 regarding the RPM market, physicians' pay schedule and cybersecurity policy.
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.